Article History
Accepted: 21 April 2023
First Online: 24 May 2023
Competing interests
: C.P. is one of the holders of a patent describing the diagnostic use of urinary TWEAK in lupus nephritis (Method of treating lupus nephritis; Grant US-9730947-B2). C.M. and C.P. serve as scientific consultants to Equillium, which is developing anti-CD6 as a therapy for lupus nephritis. The other author declares no competing interests.